H. Lundbeck, Lundbeck announces strategic alliance to market Cipramil™ and Lexapro™ in The People’s Republic of China

H. Lundbeck A/S today announced that it has entered into an agreement with Janssen-Cilag International, Zug, Switzerland, to promote, sell, and distribute Cipramil™ (citalopram) and Lexapro™ (escitalopram) in China. Xian-Janssen Pharmaceutical Ltd, Beijing, China will market and sell both products and provide regulatory support. Both Janssen-Cilag and Xian-Janssen are members of the Johnson & Johnson Group.